ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE METHOD OF ANALYSIS
SOP
1.0 OBJECTIVE:
To
lay down a procedure for the active raw material of the Ziprasidone hydrochloride monohydrate from
the Pharmacopoeial specifications.
2.0 SCOPE:
This
SOP shall be applicable in Q.C laboratory.
3.0 RESPONSIBILITY:
3.1
Q.C Analyst.
4.0 ACCOUNTABILITY:
4.1
Q.C Manager.
5.0 PROCEDURE:
5.1 Characters:
5.1.1
Appearance:
5.1.1.1
White or slightly
pink powder.
5.1.2
Solubility:
5.1.2.1
Material and equipment:
5.1.2.1.1
Glassware (3 test
tubes, 1 spatula).
5.1.2.1.2
Methanol.
5.1.2.1.3
Methylene
chloride.
5.1.2.1.4
Purified water.
5.1.2.2
Sample:
5.1.2.2.1
Small quantity.
5.1.2.3
Method:
5.1.2.3.1
Take 3 test tubes
and add small quantity of sample for testing solubility according to B.P
specifications.
5.1.2.3.2
Add purified water
in test tube 1 and observe.
5.1.2.3.3
Add methanol in
test tube 2 and observe.
5.1.2.3.4
Add methylene
chloride in test tube 3 and observe.
5.1.2.4
Observations:
5.1.2.4.1
The sample in test
tube 1 containing with purified water is practically insoluble.
5.1.2.4.2
The sample in test
tube 2 & 3 containing with methanol and methylene chloride are slightly soluble.
5.2 Identification
tests:
5.2.1
Chlorides
test:
5.2.1.1
Material and equipment:
5.2.1.1.1
Glassware
(according to requirement).
5.2.1.1.2
Centrifuge
machine.
5.2.1.1.3
Dilute nitric
acid.
5.2.1.1.4
Purified water
(q.s).
5.2.1.1.5
0.4ml of Silver
nitrate R1.
5.2.1.1.6
1.5ml of ammonia.
5.2.1.2
Sample:
5.2.1.2.1
30.0mg.
5.2.1.3
Method:
5.2.1.3.1
Take a test tube
add in it 2.0ml of water with the help of pipette.
5.2.1.3.2
Suspend 30.0mg of
sample in it.
5.2.1.3.3
Acidify with 0.15ml
of dilute nitric acid.
5.2.1.3.4
Filter it by using
filtration apparatus.
5.2.1.3.5
Take 2.0ml of the above
obtained filtrate in test tube.
5.2.1.3.6
And add 0.4ml of
silver nitrate R1.
5.2.1.3.7
Shake and allow it
to stand.
5.2.1.3.8
A curdled, white
ppt is formed.
5.2.1.3.9
Centrifuge it in
centrifugation machine, according to SOP.
5.2.1.3.10 The
obtained ppt is wash with 3 quantities, each of 1ml, of water.
5.2.1.3.11 Carry
out this operation rapidly is subdued light, degrading the fact that the
supernatant solution may not become perfectly clear.
5.2.1.3.12 Suspend
the precipitate in 2.0ml of water and add 1.5ml of ammonia.
5.2.1.4
Observations:
5.2.1.4.1
The precipitate
dissolves easily with the possible exception of a few large particles which
dissolves slowly.
5.3 Assay:
5.3.1
Apparatus:
5.3.1.1
HPLC apparatus.
5.3.1.2
Glassware
(according to the requirement).
5.3.2
Material
and reagents:
5.3.2.1
Purified water.
5.3.2.2
Methanol.
5.3.2.3
Ziprasidone
hydrochloride monohydrate CRS.
5.3.2.4
6.8g/L solution of
potassium dihydrogen phosphate R.
5.3.2.5
Phosphoric acid R.
5.3.3
Sample:
5.3.3.1
23.0mg.
5.3.4
Solvent
mixture:
5.3.4.1
Purified water R,
methanol R (40:60 v/v)
5.3.5
Test
solution:
5.3.5.1
Take a beaker of
100.0ml and add 23.0mg of the substance to be examined in it.
5.3.5.2
Add in sufficient
quantity of solvent mixture and dissolved it by using magnetic stirrer i.e. SOP.
5.3.5.3
And dilute it to
100.0ml with the solvent mixture.
5.3.6
Reference
solutions:
5.3.6.1
Take a beaker of
100.0ml and add 23.0mg of Ziprasidone hydrochloride monohydrate CRS in it.
5.3.6.2
Add in sufficient
quantity of solvent mixture and dissolved it by using magnetic stirrer i.e. SOP.
5.3.6.3
And dilute it to
100.0ml with the solvent mixture.
5.3.7
Column:
5.3.7.1
Size:
5.3.7.1.1
Length=0.15m,
5.3.7.1.2
θ=4.6mm.
5.3.7.2
Stationary
phase:
5.3.7.2.1
Spherical octylsilyl
silica gel for chromatography R (5μm).
5.3.7.3
Temperature:
5.3.7.3.1
40o.
5.3.8
Mobile
phase:
5.3.8.1
Mix 40 volumes of
methanol R and 60 volumes of a 6.8g/L solution of potassium dihydrogen
phosphate R adjusted to pH 3.0 with phosphoric acid R.
5.3.9
Flow
rate:
5.3.9.1
1.5ml/min.
5.3.10
Detection:
5.3.10.1 Spectrophotometer
at 229nm.
5.3.11 Injection:
5.3.11.1 20μL.
5.3.12 Run time:
5.3.12.1 Twice
the retention time of Ziprasidone.
5.3.13 Retention time:
5.3.13.1 Ziprasidone=
about 7 min.
5.3.14 System
suitability: reference solution:
5.3.14.1 Symmetry factor: Maximum
2.0 for the peak due to Ziprasidone.
5.3.15 Method of
analysis:
5.3.15.1 Carry
out the test protected from light and prepare the solutions immediately before
use.
5.3.15.2 Firstly
prepare the test solution, reference solution and mobile phase according to the
requirements.
5.3.15.3 The
solutions must be free from solid particles.
5.3.15.4 Prepare
the apparatus.
5.3.15.5 The
mobile phase solvent mixtures must be de-aerated prior to use either by boiling
or by applying a partial vacuum to the solvent reservoir.
5.3.15.6 Equilibrate
the column with the prescribed mobile phase, flow rate and at temperature
specified until a suitable baseline is achieved.
5.3.15.7 Test
solution of the mixture to be separated is now introduced into the mobile phase
with the help of an injector just before entering the separating column.
5.3.15.8 As
the eluate leaves the column it enters a detector, where it is continuously
monitored at the specified λ.
5.3.15.9 The
electrical signal obtained from detector is amplified and routes to recorder
which record the developed chromatogram.
5.3.15.10Calculate
the percentage content of Ziprasidone hydrochloride monohydrate (C21H22Cl2N4OS)
from the declared content of Ziprasidone hydrochloride monohydrate CRS.
5.3.16 Observations:
5.3.16.1 98.0%
to 102.0% (anhydrous substance).
6.0 REVISION LOG:
Revision No.
|
Effective Date
|
Reason
|
00
|
|
New SOP
|
7.0 REFERENCES:
7.1
The British
Pharmacopoeia. Vol II.,
Official Monograph / Ziprasidone
hydrochloride monohydrate: 2015, pp. 1209-1211.
7.2
The British
Pharmacopoeia. Vol V.,
Official Monograph /Qualitative Reactions and Tests: 2015, pp. 266-270.
7.3
USP38NF33
Volume-1 Official Monograph/ Chromatography: 2015, pp.: 424-434.
8.0 ANNEXURES:
Annexure 1: Observations
and calculations of HPLC method.
Annexure: 1
Observations
and calculations of HPLC method
Analysis
on HPLC
Instrument:
___________________
Date: _________________
Model:
___________________
Sample
solution: _______________________
Reference
standard solution: ______________
Impurities:
____________________________
(calculate
each component calculation separately)
OBSERVATIONS:
Attach
chromatogram.
CALCULATIONS:
1.
Retention time:
n= no. of peak
Retention time of unretained peak (tm)=
_____________
2.
Retention volume:
Flow rate= _______________ml/min.
3.
Retention factor:
Retention time of unretained peak (tm)=
_____________
4.
Separation factor (α):
5.
Resolution:
Retention time of unretained peak (tm)=
_____________
6.
Efficiency:
7.
Height equivalent to a theoretical plate (HETP):
Length of column = ________________________
8.
Symmetry factor (tailing factor):
9.
Response factor & Relative response factor:
Conc. (mg/ml)= ___________________
10. Relative standard deviation (%RSD):
Use formula of relative standard deviation where it is
required i.e.,
pic
11. Percentage of content:
Percentage content = (rU/rS) x (CS/CU)
x 100.
rU= peak response of substance from the sample
solution.
rS= peak response of substance from the standard
solution.
CS= concentration of substance in the standard
solution (mg/mL).
CU= concentration of substance in the sample
solution (mg/mL).
RESULTS:
________________________________________________________________________________________________________________________________________________
|
9.0 ABBREVIATIONS:
Abbreviation
|
Expanded Form
|
SOP
|
Standard
operating procedure
|
&
|
And
|
No.
|
Number
|
Ltd.
|
Limited
|
QCA
|
Quality
control active ingredient
|
F
|
Format
|
Q.C
|
Quality
control
|
Vol
|
Volume
|
g
|
Grams
|
ml
|
Milliliter
|
oC
|
Degree
centigrade
|
mg
|
Milligram
|
M
|
Molar
|
%
|
Percentage
|
R
|
Reagent
|
μm
|
Micron/
micrometer
|
g/L
|
Gram
per liter
|
CRS
|
Chemical
reference solution
|
m
|
Meter
|
θ
|
Theta
|
mm
|
Millimeter
|
ml/min
|
Milliliter
per minute
|
nm
|
Nanometer
|
μL
|
Microliter
|
Min
|
Minute
|
λ
|
Lamda
|